Top Banner
RELATED PSYCHIATRIC DISORDER SEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS
18

MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

Feb 10, 2017

Download

Health & Medicine

Dr Slayer
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

MANAGEMENT OF SUBSTANCE RELATED

PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND

INHALANTS

Page 2: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

SEDATIVE, HYPNOTIC AND ANXIOLYTIC

3 groups of drugs associated with this class of substance-related disordersBenzodiazepines (diazepam, flurazepam, oxazepam)Barbiturates (secobarbital, pentobarbital, secobarbital-

amobarbital combination)Barbiturate-like substances (methqualone, meprobamate)

Can be used as antiepileptic, muscle relaxants, and anaesthetics

Associated with physical and psychological dependence also withdrawal symptoms

Page 3: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

EPIDEMIOLOGY

• About 6% of individuals have used either sedatives or tranquilizers illicitly

• Highest prevalence was 26- to 34- years of age• Slight male predominance• About one quarter to one third of all substance-related

emergency room visits involve substances of this class

Page 4: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

ROUTES OF ADMINISTRATION

• Oral Occasionally to achieve a time-limited specific effect

(young people) Regularly to obtain a constant usually, mild intoxication

(middle age people)• Intravenous

Young people intimately involved with illegal substances Highly associated with rapid and profound tolerance,

dependence and a severe withdrawal syndrome

Page 5: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

DIAGNOSIS DSM-IV TR

Page 6: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

DIAGNOSIS DSM-IV TR

Page 7: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

FACTORS INFLUENCING DEVELOPMENT OF WITHDRAWAL

• DOSAGE• DURATION OF TREATMENT• RATE OF TAPERING

Page 8: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

MANAGEMENT

• According to bio psycho-social & spiritual model

Page 9: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

MANAGEMENT WITHDRAWAL

Page 10: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

MANAGEMENT OVERDOSE

• Gastric lavage• Activated charcoal• Careful monitoring of vital signs, CNS activity• Benzodiazepine antagonist: Flumazenil

Page 11: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

INHALANT DRUGS

Are volatile hydrocarbon that are inhaled for psychotropic effects. Eg : Toluene, n-hexane, methyl butyl ketone, tricholoroethylene,

trichloroethane, dichloromethane, gasoline, butane. Sold in 4 commercial classes:

o Solvents for glue & adhesiveso Propellants for aerosol paint sprays, hair sprays, frying pan sprays,

shaving creamo Thinners (paint products, typing correction fluids)o Fuels

Page 12: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

DIAGNOSIS DSM-IV TR

Page 13: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

• Symptoms of mild intoxication similar to intoxication with alcohol or sedative-hypnotics

• Possible toxic effects: - Brain damage - Liver damage- BM depression - Peripheral neuropathies- Immunosuppression

Psychological effects Physical effectsEuphoria Ataxia

Belligerence ConfusionAssaultiveness Disorientation

Impaired judgment Slurred speechImpulsiveness Dizziness

Depressed reflexesNystagmus

Page 14: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

• Withdrawal rarely developed • Characterized by:

IrritabilitySleep disturbancesJittersSweatsNausea, vomitingTachycardiaHallucination & delusion (sometimes)

Page 15: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

MANAGEMENT

• According to bio psycho-social & spiritual modelInvestigations

Biology Psychosocial

Get information from family members

Page 16: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

MANAGEMENT

Page 17: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS

REFERENCES

• Kaplan & Sadock’s Pocket Handbook of Clinical Psychiatry, 5th Edition

• Kaplan & Sadock’s Synopsis of Clinical Psychiatry, 10th Edition

Page 18: MANAGEMENT OF SUBSTANCE RELATED PSYCHIATRIC DISORDERSEDATIVE, HYPNOTIC AND ANXIOLYTIC DRUGS AND INHALANTS